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This study describes the epidemiology of extrapul-
monary tuberculosis (TB) in the Netherlands from 1993
through 2001. We assessed whether the increasing num-
bers of inhabitants with a non-Western ethnic background
had an effect on the number of extrapulmonary patients.
We used data from the Netherlands Tuberculosis Register
and included all cases of TB diagnosed in the Netherlands
between January 1, 1993, and December 31, 2001.
Information on age, sex, nationality, year of diagnosis, cul-
ture result, anatomic location of the site of disease, and HIV
status was retrieved from the register. Of 13,258 patients
with TB, 8,216 (62%) had pulmonary TB, and 5,042 (38%)
had extrapulmonary TB. Non-Dutch nationals were more
likely to have most types of extrapulmonary TB. The growth
of the number of inhabitants with a non-Western ethnic
background in the Netherlands explains the proportional
growth of extrapulmonary TB. Physicians need to be aware
of the changing clinical picture of TB.
T
uberculosis (TB) is a major public health problem,
affecting 8 million persons per year worldwide (1).
The global incidence rate of TB per capita is growing by
≈1.1% per year (1). Contrary to the increasing number of
TB cases in developing countries, the number of cases in
industrialized countries is stable or decreasing (2–4). In the
United States, a decreasing trend of the total number of TB
patients is seen with an increasing proportion of TB cases
with extrapulmonary TB, resulting in a rising proportion
from 7.8% in 1964 to 20% in 2001 (5–8). Both the HIV
epidemic and changes in population demographics, with
rising numbers of immigrants, are being held responsible
for this proportional increase of extrapulmonary TB
(6,7,9). A recent study of extrapulmonary TB in Hong
Kong Special Administrative Region, People’s Republic of
China showed that 22.3% of the TB cases were extrapul-
monary (10), while a small Canadian study found a pro-
portion of 46% (11). No national studies about
extrapulmonary TB in developing countries are known.
Extrapulmonary TB refers to TB outside the lungs.
Mycobacteria may spread through lymphatic or hematoge-
nous dissemination to any tract or through coughing and
swallowing to the gastrointestinal tract. Bacteria may
remain dormant for years at a particular site before causing
disease. Since extrapulmonary TB can affect virtually all
organs, it has a wide variety of clinical manifestations,
which causes difficulty and delay in diagnosis (7,8).
Obtaining material for culture confirmation of extrapul-
monary TB is much more difficult than obtaining material
for culture confirmation of pulmonary TB (7).
Extrapulmonary TB is more often diagnosed in women
and young patients (6,7,9–13). In the United States, extra-
pulmonary TB is associated with ethnic minorities and
those born in other countries (6). In many countries,
patients from Asian origin are known to have a higher inci-
dence of extrapulmonary TB, especially lymphatic TB
(11,14–17). A study of Somali TB patients in Minnesota
showed frequent lymphatic TB as well (18). In HIV-infect-
ed patients the frequency of extrapulmonary TB depends
on the degree of decreased cellular immunity (19,20). In
patients with <100 CD4 cells/mL, extrapulmonary and dis-
seminated TB counts for 70% of all forms of TB (21).
The Netherlands has a low incidence of HIV and, sim-
ilar to other industrialized countries, a decreasing TB inci-
dence rate. TB was a common disease in the nineteenth
century, but after the Second World War the incidence rate
declined rapidly (22). During the last decade, the numbers
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the Netherlandsof inhabitants with a non-Western ethnic background has
been growing (23). The proportion of TB patients with a
non-Dutch nationality has increased from 30% in 1980 to
63% in 2000 (22,24,25). Dutch policy regulates the screen-
ing by chest radiograph of immigrants from countries with
a high prevalence who intend to stay for more than 3
months (26). No studies have described the epidemiology
of extrapulmonary TB in the Netherlands, with the excep-
tion of 1 study on bone and joint TB (27).
This article describes the epidemiology of extrapul-
monary TB in the Netherlands between 1993 and 2001.
Our main focus is on the relation between extrapulmonary
TB and nationality. We assess whether the increasing num-
ber of inhabitants with a non-Western ethnic background
has had an effect on the number of extrapulmonary
patients.
Methods
For this study, we used data from the Netherlands
Tuberculosis Register (NTR), an anonymous case register
held by KNCVTuberculosis Foundation. Every TB patient
reported to 1 of the 45 municipal health services in the
Netherlands is included in this register. Reporting to the
register is voluntary. Comparison with the mandatory noti-
fication system of the Ministry of Health suggests 99%
completeness (28). We included all cases of TB diagnosed
in the Netherlands from January 1, 1993 through
December 31, 2001. Information on age, sex, and nation-
ality, as recorded in the passport, year of diagnosis, culture
result, anatomic location of the site of disease, and HIV
status was retrieved from the register. Non-Dutch national-
ity was divided into 7 different nationality groups: Europe
(central and eastern: Poland, Czech, Slovakia, Hungary,
Romania, Bulgaria, Albania and the countries of the for-
mer Yugoslavia and the former Soviet Union), Turkey,
Morocco, Somalia, Africa (other), Asia, and other coun-
tries. HIV testing is not a standard procedure for TB
patients in the Netherlands. We considered case-patients
with a record of impaired immunity due to HIV infection
as HIV infected and all others as HIV status unknown.
Information about the anatomic location of disease was
registered using 2 different classification systems. In the
NTR, the location of TB is generally divided into 3 cate-
gories, pulmonary, extrapulmonary, or combined pul-
monary and extrapulmonary disease, and the disease is
classified according to the site of the disease by using the
International Classification of Diseases 9th revision (ICD-
9). We first used the information from the ICD-9 classifi-
cation to divide the patients into a pulmonary TB group,
i.e., major site of disease location inside the lungs, and an
extrapulmonary TB group, i.e., the major site of disease
was outside the lungs. Thereafter, 8 types of extrapul-
monary disease were defined: lymphatic, pleural, bone
and/or joint, genitourinary, miliary, peritoneal, meninges
and/or central nervous system (CNS), and all other sites
combined. If information from the ICD-9 classification
was not available, we used the general information about
location of the disease. Case-patients with general location
pulmonary disease were allocated to the pulmonary TB
group and those with extrapulmonary disease were allocat-
ed to the extrapulmonary TB group, site of disease unspec-
ified. Patients for whom no information about the ICD-9
classification was available, and with the general location
of combined pulmonary and extrapulmonary disease, were
excluded from the analysis.
Each patient was included once in our dataset. If a
patient was reported to the register with TB more than
once from January 1, 1993, through December 31, 2001,
only the information from the first registration was includ-
ed in the dataset. Patients with a culture diagnosis of
Mycobacterium bovis and M. bovis BCG were excluded as
were patients with missing data for age, sex, or nationality
We obtained the total number of inhabitants with Dutch
and non-Dutch nationality in the Netherlands from January
1, 1993, through January 1, 2002, from the Central Bureau
of Statistics of the Netherlands (29). We used these figures
as denominators to assess trends in time of the incidence of
extrapulmonary and pulmonary TB by Dutch or non-Dutch
nationality with Poisson regression. One-way analysis of
variance (ANOVA) was used to analyze differences in
means of age. We used the χ2 test to compare the propor-
tions of pulmonary and extrapulmonary TB cases and non
parametric tests to compare time to TB diagnosis from
immigration for foreign born persons. Differences between
pulmonary TB and the 8 separate types of extrapulmonary
TB, were tested by using logistic regression, with pul-
monary disease as the reference category. The variables
age, sex, nationality and HIV status were included in a
multivariate logistic regression model to adjust for con-
founding. Statistical analysis was performed by using
SPSS version 11.5 for Windows (SPSS Inc, Chicago, IL,
USA).
Results
Between January 1993 and December 2001, 13,943
cases of TB were reported to the Netherlands Tuberculosis
Register, 10,688 (76.7%) were culture positive. The 270
case-patients that were reregistrations were excluded. Also
excluded were 135 patients who had a diagnosis of M.
bovis or M. bovis BCG infection; 190 patients with miss-
ing information about age, sex, or nationality; and 90
patients with a missing ICD-9 classification and combined
pulmonary and extrapulmonary disease.
Of the total of 13,258 (95.1%) TB patients available for
analysis, 8,216 (62.0%) had pulmonary TB, and 5,042
(38.0%) had an extrapulmonary major site of disease
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slightly larger among the pulmonary (71.5%) than among
the extrapulmonary TB patients (67.4%) (χ2 test, p<0.01).
The male-to-female ratio was 1.5:1. Male TB patients were
slightly younger than female TB patients (ANOVA,
p<0.01), the mean age for men was 39.0 years and for
women, 40.2 years. Most TB patients (57.1%) were non-
Dutch. Of the 7,576 non-Dutch patients, 1,692 (22.3%)
were Somali, 1,600 (21.1%) were Asian, 1,267 (16.7%)
were Moroccan, and 1,245 (16.4%) were African (other).
Asians included 32 different nationalities; the largest num-
ber of patients was from Pakistan (243 cases), followed by
Indonesia (239 patients) and the People’s Republic of
China (179 patients). The African (other) group consisted
of 48 nationalities with the largest numbers of patients
being from Ethiopia (163 patients) and Angola (146
patients). Patients from Somalia, Asia, and Morocco more
frequently had a diagnosis of extrapulmonary TB then did
Dutch patients, whereas patients from central and eastern
Europe had extrapulmonary TB less often (χ2 test, p<0.01).
Non-Dutch patients were significantly younger than Dutch
patients (ANOVA p<0.01), the mean ages were 31.7 and
49.8 years, respectively. The male-to-female ratio was
1.4:1 among Dutch patients and 1.5:1 among non-Dutch
patients (χ2 test, p<0.01). Among the non-Dutch, 41.7% of
the TB patients had extrapulmonary TB, compared with
33.1% of the Dutch TB patients (p<0.01). No interaction
was found between the variables age, nationality, sex, and
HIV status.
Between 1993 and 2001 the total number of pulmonary
TB cases decreased (rate ratio per year 0.96, 95% confi-
dence interval [CI] 0.95–0.96; p<0.01), especially among
the Dutch population (Figure). The total number of extra-
pulmonary patients showed no significant change in time
(rate ratio per year 1.00, 95% CI 0.99–1.02; p = 0.40), but
the number of extrapulmonary TB patients with a Dutch
nationality decreased (rate ratio per year 0.96, 95% CI
0.94–0.98; p<0.01), while the number of extrapulmonary
TB patients with a non-Dutch nationality increased (rate
ratio per year 1.06, 95% CI 1.04–1.07; p<0.01).
Extrapulmonary TB was relatively more prevalent
among female (45.3%) than among male TB patients
(33.1%) (p<0.01). The mean age of extrapulmonary TB
patients was slightly higher (40.3 years) than that of pul-
monary cases (39.0 years; ANOVA p<0.01). The most fre-
quent types of extrapulmonary TB were lymphatic TB
(1,963 cases), pleural TB (1,036 cases), and TB of the
bones and/or joints (465 cases) (Table 2). Other sites
Extrapulmonary Tuberculosis, the Netherlands
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(miliary TB) cases, while for 379 of the extrapulmonary
cases, site of disease was not recorded. The proportion of
HIV-infected patients ranged from 0.9% (genitourinary
TB) to 16.7% (miliary TB), depending on the site of dis-
ease (Table 3). The median time since immigration into the
Netherlands to diagnosis of TB among non-Dutch was
36.0 months (mean 73.0 months) and varied from 7.9
months in central and eastern Europeans to 9.0 years in
Moroccans. Among all non-Dutch pulmonary TB had a
shorter time from immigration to diagnosis (median 24.0
months) than extrapulmonary TB (median 44.6 months)
(Mann-Whitney U test p<0.01).
The genitourinary tract was the site of TB that had the
smallest proportion of non-Dutch patients (34.2%) while
80.9% of the patients with peritoneal TB were non-Dutch.
Somali TB patients had a strongly increased frequency of
peritoneal TB (crude odds ratio 9.4, adjusted odds ratio
[AOR] 12, 95% CI 7.6–20), lymphatic TB (crude odds
ratio 7.2, AOR 7.8, 95% CI 6.6–9.3) and TB of bones
and/or joints (crude odds ratio 3.5, AOR 6.1, 95% CI
4.5–8.3) than the Dutch (Table 4). Asian TB patients had a
higher frequency of lymphatic TB (crude odds ratio 4.1,
AOR 4.2, 95% CI 3.6–5.0) and peritoneal TB (crude odds
ratio 3.2, AOR 3.4, 95% CI 2.0–5.9) than the Dutch. The
proportion of TB of the bones and or joints, genitourinary
TB, and miliary TB compared to pulmonary TB increased
with the age of the patients. Both the age groups ≤14 years
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Figure. Relative incidence of pulmonary tuberculosis (PTB) and
extrapulmonary tuberculosis (EPTB) among Dutch and non-Dutch
residents, the Netherlands, 1993–2001. and 45–64 years were associated with TB of the meninges
and/or CNS, in univariate analysis (crude odds ratio 3.9
and 1.8, respectively). When the study population was
stratified in <14 years and >15 years age groups, all types
of extrapulmonary TB were associated with the oldest age
group, except for TB of the meninges and/or CNS, which
was weakly associated with the youngest age group (AOR
1.7, 95% CI 0.9–3.1). HIV infection was positively associ-
ated with miliary TB (AOR 7.4, 95% CI 4.9–11) and TB of
the meninges and/or CNS (AOR 3.3, 95% CI 1.6–6.7) and
negatively associated with pleural and genitourinary TB.
Discussion
In the Netherlands, the number of inhabitants with a
non-Western ethnic background increased over the past 2
decades (23). The Netherlands is likely to remain an immi-
gration destination for persons from non-Western coun-
tries, although changes in immigration laws can change
this situation (23,24). We assessed the effect of these
immigration patterns on the incidence of pulmonary and
extrapulmonary TB.
Between 1993 and 2001, the number of pulmonary TB
cases per year declined, whereas the number of extrapul-
monary TB cases remained stable, thus showing a propor-
tional increase. This trend is similar to the trend observed
in studies in the United States (6,7). Our study shows that
a non-Dutch nationality, especially Somali and Asian, was
positively associated with extrapulmonary TB when com-
pared with the results for pulmonary TB. This finding sug-
gests that the most likely explanation for the proportional
increase of extrapulmonary TB is the growth of the num-
ber of inhabitants with a non-Western ethnic background.
Our analysis showed that persons from non-Western
national groups, especially Somalis, Asians, and
Moroccans, were more likely to receive a diagnosis of
most types of extrapulmonary TB than Dutch nationals.
When looking at the absolute number of patients with lym-
phatic and peritoneal TB exclusively, patients with Somali
nationality even outnumbered Dutch patients (497 and 58
vs 441 and 34, respectively). In agreement with the litera-
ture, we found a strongly positive association between
Somali nationality and lymphatic and bone and/or joint TB
(18,27) and between Asian nationalities and lymphatic TB
(6,10,11,16). Our study demonstrated a statistically signif-
icant, strong, positive association between peritoneal TB
and Somali, Moroccan, or Asian nationality. In contrast,
Extrapulmonary Tuberculosis, the Netherlands
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non-Dutch patients when results were compared with
those of the Dutch patients, a finding that we cannot
explain.
Several explanations are possible for the association of
extrapulmonary TB and a non-Dutch nationality. Non-
Dutch persons may have a higher frequency of extrapul-
monary TB due to an impaired immunity caused by factors
such as vitamin D deficiency (11,16,30,31), dietary
changes (16), and restricted social conditions (16,18),
which cause an endogenous TB infection to reactivate
from extrapulmonary or pulmonary sites. Also genetic fac-
tors (32), for example the presence of polymorphism of the
NRAMP1 gene (33,34) may contribute to differences in the
susceptibility to acquire extrapulmonary TB. Furthermore,
M. tuberculosis strains circulating outside the Netherlands
may be genetically different from those circulating in the
Netherlands and cause more extrapulmonary TB.
Alimitation in our study is the use of different methods
of case finding, since immigrants from countries with a
high prevalence are screened for pulmonary TB, but not
for extrapulmonary TB (26). This circumstance could lead
to a possible underestimation of extrapulmonary TB
among immigrants, which would make the relationships
found in this study even stronger. On the other hand, selec-
tion bias is possible when physicians disproportionately
suspect and diagnose extrapulmonary TB among certain
groups of patients such as non-Western patients. By
including 97.0% of all reported new cases of TB in the
analysis (13,258 of 13,673 new cases), we tried to mini-
mize bias on inclusion in the study. Fewer patients with
extrapulmonary TB had a positive culture than did patients
with pulmonary TB (67.4% vs 71.5%). Thus patients with
extrapulmonary TB may be misdiagnosed. However, a
RESEARCH
1380 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 9, September 2006sensitivity analysis, which included only the culture-posi-
tive cases, did not change the conclusions of the logistic
regression analysis. Also misdiagnosis of M. bovis as M.
tuberculosis may have occurred in cases in which no cul-
ture result was available. Of the 114 M. bovis patients
excluded from the analysis, all locations of TB were iden-
tified: 7 patients had pleural TB, 30 had lymphatic TB, 2
had meningeal TB, 3 had peritoneal TB, 8 had TB of bones
and/or joints, 8 had genitourinary TB, 5 had miliary TB, 5
had other extrapulmonary TB, 42 had pulmonary TB, and
4 had extrapulmonary TB not specified.
It should be noted that nationality in the NTR is not
always recorded based on passport; sometimes ethnic
background is used. Furthermore, a difference in the defi-
nition of extrapulmonary TB used in different studies com-
plicates mutual comparison.
Many studies suggest that HIV-induced immunosup-
pression is associated with extrapulmonary disease
(7,35–37), especially with lymphatic and miliary TB
(38,39). In the Netherlands, HIV testing is not a standard
procedure for TB patients, which may have led to a possi-
ble selection bias in our study. A possible explanation for
the absence of associations between HIV infection and
most types of extrapulmonary TB in our study can be
found in the introduction of the highly active antiretroviral
therapy (HAART) in 1996 (40). HIV-infected patients
treated with HAART will have less impaired immunity
(39).
Diagnosing extrapulmonary TB can be difficult, so a
high index of suspicion remains important. In immigrants
from countries with highly endemic TB, a medical history,
physical examination, basic laboratory tests, and chest
radiograph can lead to a diagnosis. Since TB can occur in
all organs, further examination depends on the possible
site of infection.
In summary, our analysis showed that there is a propor-
tional increase of extrapulmonary TB in the Netherlands.
The growth of the number of inhabitants with a non-
Western ethnic background in the Netherlands explains the
proportional growth of extrapulmonary TB. Increased
awareness among physicians about the changing clinical
picture and up-to date knowledge about diagnosis of TB is
warranted.
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